Healthwell Acquisition Corp. I
NASDAQ:HWEL
10.475 (USD) • At close November 28, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.195 | 0.375 | 1.423 | 0.555 | 0.263 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -1.195 | -0.375 | -1.423 | -0.555 | -0.263 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0.318 | 0 | 0 | 0.318 | 0 | 0.157 | 0.006 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.001 | 0 | -0.318 | 0.001 | 0.263 | 0.318 | 0 | 0.157 | 0.006 | 0 |
| Other Expenses
| -0 | 0.426 | 0.656 | 0.605 | 0.314 | 0 | -0.441 | 0 | 0 | 0 |
| Operating Expenses
| 1.245 | 0.05 | -0.318 | 0.05 | 0.05 | 0.368 | -0.441 | 0.131 | 0.006 | 0 |
| Operating Income
| -1.245 | -0.426 | -0.338 | -0.605 | -0.314 | -0.368 | -0.505 | -0.288 | -0.006 | -0 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.65 | 1.359 | 4.43 | 0.64 | 2.958 | 5.768 | -0.976 | 6.266 | 0 | 0 |
| Income Before Tax
| -0.595 | 0.933 | 4.092 | 0.036 | 2.644 | 5.4 | -1.48 | 5.978 | -0.006 | -0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.65 | 0.557 | 0.476 | 0.283 | -2.429 | 0 | 1.039 | 1.021 | 0 | 0 |
| Net Income
| -1.246 | 0.376 | 3.616 | -0.248 | 2.644 | 5.4 | -2.52 | 5.978 | -0.006 | -0 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.04 | 0.012 | 0.12 | -0.008 | 0.16 | 0.17 | -0.12 | 0.28 | -0 | -0.001 |
| EPS Diluted
| -0.04 | 0.012 | 0.12 | -0.008 | 0.16 | 0.17 | -0.12 | 0.28 | -0 | -0.001 |
| EBITDA
| -1.245 | -0.426 | -4.767 | -0.605 | -0.314 | -0.368 | -1.48 | -7.574 | -0.006 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |